The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation.
about
The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The anticancer effect of meben ...... ndent inflammasome activation.
@en
type
label
The anticancer effect of meben ...... ndent inflammasome activation.
@en
prefLabel
The anticancer effect of meben ...... ndent inflammasome activation.
@en
P2093
P2860
P921
P1476
The anticancer effect of meben ...... ndent inflammasome activation.
@en
P2093
Angelica Loskog
Claes Andersson
Jenny Rubin
Kristin Blom
Lena Lenhammar
Malin Berglund
Malin Jarvius
Mårten Fryknäs
Vendela Parrow
Wojciech Senkowski
P2860
P304
P356
10.1080/08923973.2017.1320671
P577
2017-05-04T00:00:00Z